Hims & Hers misses Q2 EPS but beats revenue estimates, raises full-year revenue forecast.

Hims & Hers Health, Inc. reported a second-quarter 2026 earnings per share (EPS) loss of $0.10, missing the expected loss of $0.05. However, the company exceeded revenue expectations with $753.21 million, above the $698.89 million estimate, driven by subscriber growth and expanded personalized healthcare services. Despite the quarterly loss, Hims & Hers raised its annual revenue forecast to $3.1-$3.3 billion, signaling confidence in future growth. Financial ratios show a mixed picture, with a high debt-to-equity ratio of 4.77 and a current ratio below 1, indicating some financial leverage and liquidity concerns.